Allergic respiratory disease care in the COVID-19 era: A EUFOREA statement

Glenis K. Scadding*, Peter W. Hellings, Claus Bachert, Leif Bjermer, Zuzana Diamant, Philippe Gevaert, Anette Kjeldsen, Jorge Kleine-Tebbe, Ludger Klimek, Antonella Muraro, Graham Roberts, Andreas Steinsvik, Martin Wagenmann, Ulrich Wahn

*Corresponding author for this work

Research output: Contribution to journalJournal articleCommunication

4 Downloads (Pure)


Spring and Summer 2020 are unique in that the challenges of care for those suffering from pollen allergy coincide with the COVID-19 pandemic. Several considerations are important to allow optimal care of allergic rhinitis (AR) and asthma and hence prevention of coronavirus spread through sneezing, rhinorrhoea and coughing. This compact overview of recommendations by the EUFOREA expert teams on allergic airway diseases and AIT is based on investigation of the current COVID-19 literature in association with the key words above and shared clinical experience of the experts involved. It deals with similarities and differences between AR and coronavirus infection, specific recommendations for allergic disease care in the COVID-19 era, including guidance on allergen specific immunotherapy, AIT.

Original languageEnglish
Article number100124
JournalWorld Allergy Organization Journal
Issue number5
Number of pages4
Publication statusPublished - May 2020


  • Allergen-specific immunotherapy
  • Allergy
  • Asthma
  • Control
  • COVID-19
  • Rhinitis
  • Smell and taste
  • Symptoms
  • Treatment

Fingerprint Dive into the research topics of 'Allergic respiratory disease care in the COVID-19 era: A EUFOREA statement'. Together they form a unique fingerprint.

  • Cite this

    Scadding, G. K., Hellings, P. W., Bachert, C., Bjermer, L., Diamant, Z., Gevaert, P., Kjeldsen, A., Kleine-Tebbe, J., Klimek, L., Muraro, A., Roberts, G., Steinsvik, A., Wagenmann, M., & Wahn, U. (2020). Allergic respiratory disease care in the COVID-19 era: A EUFOREA statement. World Allergy Organization Journal, 13(5), [100124].